104 related articles for article (PubMed ID: 29105934)
21. EGFR kinase possesses a broad specificity for ErbB phosphorylation sites, and ligand increases catalytic-centre activity without affecting substrate binding affinity.
Fan YX; Wong L; Johnson GR
Biochem J; 2005 Dec; 392(Pt 3):417-23. PubMed ID: 16122376
[TBL] [Abstract][Full Text] [Related]
22. Affinity enhancement of nanobody binding to EGFR: in silico site-directed mutagenesis and molecular dynamics simulation approaches.
Farasat A; Rahbarizadeh F; Hosseinzadeh G; Sajjadi S; Kamali M; Keihan AH
J Biomol Struct Dyn; 2017 Jun; 35(8):1710-1728. PubMed ID: 27691399
[TBL] [Abstract][Full Text] [Related]
23. Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation.
Diermeier S; Horváth G; Knuechel-Clarke R; Hofstaedter F; Szöllosi J; Brockhoff G
Exp Cell Res; 2005 Apr; 304(2):604-19. PubMed ID: 15748904
[TBL] [Abstract][Full Text] [Related]
24. Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cells.
Song RX; Zhang Z; Chen Y; Bao Y; Santen RJ
Endocrinology; 2007 Aug; 148(8):4091-101. PubMed ID: 17525128
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of EGFR Activation by Bivalent Ligands Based on a Cyclic Peptide Mimicking the Dimerization Arm Structure of EGFR.
Toyama K; Kobayakawa T; Nomura W; Tamamura H
Chem Pharm Bull (Tokyo); 2018; 66(11):1083-1089. PubMed ID: 30381661
[TBL] [Abstract][Full Text] [Related]
26. Bicyclic Peptides as Next-Generation Therapeutics.
Rhodes CA; Pei D
Chemistry; 2017 Sep; 23(52):12690-12703. PubMed ID: 28590540
[TBL] [Abstract][Full Text] [Related]
27. Epidermal growth factor (EGF) receptor ligands in the chicken ovary: I. Evidence for heparin-binding EGF-like growth factor (HB-EGF) as a potential oocyte-derived signal to control granulosa cell proliferation and HB-EGF and kit ligand expression.
Wang Y; Li J; Ying Wang C; Yan Kwok AH; Leung FC
Endocrinology; 2007 Jul; 148(7):3426-40. PubMed ID: 17395697
[TBL] [Abstract][Full Text] [Related]
28. Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cells.
Johnson FM; Saigal B; Donato NJ
J Cell Physiol; 2005 Nov; 205(2):218-27. PubMed ID: 15887238
[TBL] [Abstract][Full Text] [Related]
29. Single-molecule analysis of epidermal growth factor binding on the surface of living cells.
Teramura Y; Ichinose J; Takagi H; Nishida K; Yanagida T; Sako Y
EMBO J; 2006 Sep; 25(18):4215-22. PubMed ID: 16946702
[TBL] [Abstract][Full Text] [Related]
30. The regulatory role of the juxtamembrane region in the activity of the epidermal growth factor receptor.
Boran AD
Biochem Soc Trans; 2012 Feb; 40(1):195-9. PubMed ID: 22260689
[TBL] [Abstract][Full Text] [Related]
31. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO
Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193
[TBL] [Abstract][Full Text] [Related]
32. Escherichia coli expression and refolding of E/K-coil-tagged EGF generates fully bioactive EGF for diverse applications.
Le PU; Lenferink AE; Pinard M; Baardsnes J; Massie B; O'Connor-McCourt MD
Protein Expr Purif; 2009 Apr; 64(2):108-17. PubMed ID: 19061959
[TBL] [Abstract][Full Text] [Related]
33. Heterogeneities in EGF receptor density at the cell surface can lead to concave up scatchard plot of EGF binding.
Mayawala K; Vlachos DG; Edwards JS
FEBS Lett; 2005 Jun; 579(14):3043-7. PubMed ID: 15896781
[TBL] [Abstract][Full Text] [Related]
34. Epidermal growth factor promotes epidermal growth factor receptor nuclear accumulation by a pathway dependent on cytoskeleton integrity in human breast cancer cells.
Cortes-Reynosa P; Robledo T; Salazar EP
Arch Med Res; 2009 Jul; 40(5):331-8. PubMed ID: 19766894
[TBL] [Abstract][Full Text] [Related]
35. Computational modeling reveals molecular details of epidermal growth factor binding.
Mayawala K; Vlachos DG; Edwards JS
BMC Cell Biol; 2005 Nov; 6():41. PubMed ID: 16318625
[TBL] [Abstract][Full Text] [Related]
36. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
Huang Y; Li X; Jiang J; Frank SJ
Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
[TBL] [Abstract][Full Text] [Related]
37. Trophoblast subtype-specific EGFR/ERBB4 expression correlates with cell cycle progression and hyperplasia in complete hydatidiform moles.
Fock V; Plessl K; Fuchs R; Dekan S; Milla SK; Haider S; Fiala C; Knöfler M; Pollheimer J
Hum Reprod; 2015 Apr; 30(4):789-99. PubMed ID: 25740878
[TBL] [Abstract][Full Text] [Related]
38. Peptabody-EGF: a novel apoptosis inducer targeting ErbB1 receptor overexpressing cancer cells.
Fattah OM; Cloutier SM; Kündig C; Felber LM; Gygi CM; Jichlinski P; Leisinger HJ; Gauthier ER; Mach JP; Deperthes D
Int J Cancer; 2006 Nov; 119(10):2455-63. PubMed ID: 16858684
[TBL] [Abstract][Full Text] [Related]
39. Dynamic conformational transitions of the EGF receptor in living mammalian cells determined by FRET and fluorescence lifetime imaging microscopy.
Ziomkiewicz I; Loman A; Klement R; Fritsch C; Klymchenko AS; Bunt G; Jovin TM; Arndt-Jovin DJ
Cytometry A; 2013 Sep; 83(9):794-805. PubMed ID: 23839800
[TBL] [Abstract][Full Text] [Related]
40. Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics.
Li Z; Zhao R; Wu X; Sun Y; Yao M; Li J; Xu Y; Gu J
FASEB J; 2005 Dec; 19(14):1978-85. PubMed ID: 16319141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
